labvie

Yes, I have but we would have to be considered for summer in order to postpone our series A which we are commencing. If we raise money, we will not be able to do YC later on. I just know.

The truth is we didn't want to sell to big pharma, they would have shelved likely. Cures don't make profit, treatments do. This is why we wanted to create a company that could put this out to market in less than ten years, get it approved by the FDA as a breakthrough and have it in market in 5 years. Subsidize it to people with need and low income.

These are the reasons we felt being in control of the destiny of it was the safest bet. But so far, it seems that the easy way out is to sell it, which would mean it would not become what we want it to be, a cure to various diseases.

I've never raised before. It's the first time we create a private company based on the research we are doing. I contacted somewhere around 700, which includes partners, associates, juniors from about 100 VC firms.

What is ironic is that I actually have Dave Mcclure's email/number, I reached out to him personally and he didn't so much as respond. It was quite a realization of how things work in SV. This week has been very tough, and disappointing. We will continue to bootstrap using grants from the NIH until something better comes along our way.